Meaningful patient involvement in HTA decision making: where do we go from here?

Episode 23 • October 07, 2025 • 00:19:09
Meaningful patient involvement in HTA decision making: where do we go from here?
LifeSci Talks
Meaningful patient involvement in HTA decision making: where do we go from here?

Oct 07 2025 | 00:19:09

/

Show Notes

In this episode of LifeSci Talks, Mark Wade, Global Practice Leader at TransPerfect Life Sciences, sits down with Alice Biggane, Outcomes Innovation and Research Lead at Pfizer UK, to discuss how various PRO measures inform and impact reimbursement decisions for HTA driven markets.  Together they unpack what data sources and methods exist for the quantification and understanding of HRQoL for cost-effectiveness decision making and the complex interplay between the need to reduce burden and increase transparency through standardization, while maintaining the crucial and nuanced balance of different stakeholder requirements. Tune in to learn how leading organizations are working to build more inclusive, efficient, and patient-focused clinical trials, and accelerating patient-access to new health technologies.

Other Episodes

Episode 6

September 28, 2023 • 00:12:09
Episode Cover

Data Science: The New Frontier with Dr. Elizabeth Bacci

In this episode of LifeSci Talks, Mark Wade, Global Practice Leader at TransPerfect Life Sciences sits down with Dr. Elizabeth Bacci, Senior Research Scientist...

Listen

Episode 15

August 08, 2024 • 00:01:28
Episode Cover

From Interview to Endpoint: Understanding the Importance of Patient Listening to Build Better Outcomes

In this episode of TransPerfect LifeSci Talks, Mark Wade, Global Practice Leader at TransPerfect Life Sciences sits down with John Reites, Co-Founder and CEO...

Listen

Episode 1

February 10, 2026 • 00:20:13
Episode Cover

Building Fit-for-Purpose PRO Instruments: Focused Modern Measures Over General Instruments

In this episode of LifeSci Talks, Mark Wade, Global Practice Leader & COA SME at TransPerfect Life Sciences, is joined by Katja Rudell, VP...

Listen